$COAG
Hemab Therapeutics Holdings, Inc. Common Stock
XNAS
Why is COAG down today? It is at $48.79 (-5.56%), and our scanner flagged it 97 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment COAG spikes, and full due diligence on COAG — key stats, earnings, dilution and insider activity. Free.
Get free $COAG alerts the moment volume spikes
Our scanner flagged $COAG 97 times in the last 30 days. Create a free account to track $COAG, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $48.79
- Change today
- -5.56%
- Previous close
- $51.66
- 52-week range
- $23.00 – $55.42
- Market cap
- $2.45B
- Institutional own.
- 77.46%
- Total held
- 80.1%
- Tradeable float
- 9.3M 20% of shares · after 3% insiders + 77% institutions
- Short interest
- 2.0M ▲ +23% vs prior · as of 2026-07-31
- Short % of float
- 22.0%
- Days to cover
- 4.3d
- Avg daily volume
- 364K
- Exchange
- XNAS
- 5mthin
- 166x
- 15mthin
- 166x
- 1hthin
- 1.9x
- 1D
- 1.1x
Get free COAG + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $COAG down today?
COAG is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on COAG today, peaking at 2.0x its normal volume.
Likely catalystHemab Therapeutics Holdings, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedAug 14, 2026 · 6 days agoAnalyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying10 open-market buys2 buys, 0 sells last 3 months (14/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +62K 0.1% of company | added 0.8% | 7.81M | $1.5M at $24.98 | Jun 16, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +6K 0.01% of company | added <0.1% | 6.38M | $153K at $24.89 | Jun 15, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +996 | added <0.1% | 7.74M | $25K at $24.94 | May 20, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +4K | added <0.1% | 6.38M | $95K at $24.97 | May 19, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +6K 0.01% of company | added <0.1% | 7.74M | $159K at $24.90 | May 12, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +40K 0.09% of company | added 0.5% | 7.73M | $976K at $24.47 | May 11, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +1K | added <0.1% | 6.33M | $37K at $24.98 | May 8, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Bought (open market) | +10K 0.02% of company | added 0.2% | 6.32M | $241K at $24.34 | May 7, 26 |
Ra Capital Management, L.P. Director | Bought (open market) | +68K 0.1% of company | added 0.9% | 7.68M | $1.6M at $23.77 | May 6, 26 |
Ra Capital Management, L.P. Director | Bought (open market) | +97K 0.2% of company | added 1.6% | 6.25M | $2.4M at $24.59 | May 5, 26 |
Maraganore John Director | Acquired (grant/award) | +36K 0.08% of company | n/a | 36K | n/a | May 4, 26 |
Novo Holdings A/S Beneficial Owner (10%) | Acquired (grant/award) | +4.18M 8.9% of company | n/a | 4.18M | n/a | May 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $COAG runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 2,512,500 new shares
- Priced at $17/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$COAG Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$COAG Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
COAG stock FAQ
Why is $COAG down today?
COAG is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on COAG today, peaking at 2.0x its normal volume.
What is the COAG stock price today?
COAG last traded at $48.79, down 5.56% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live COAG alerts?
The COAG Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged COAG 97 times in the last 30 days.
What exchange is COAG on?
COAG (Hemab Therapeutics Holdings, Inc. Common Stock) trades on XNAS, with a market cap of about $2.45B.
Is COAG good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge COAG for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.